Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

Lignende værker

• Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
  af: Chen, D., et al.
  Udgivet: (2011)
• From Bortezomib to other Inhibitors of the Proteasome and Beyond
  af: Buac, Daniela, et al.
  Udgivet: (2013)
• Clinical development of novel proteasome inhibitors for cancer treatment
  af: Yang, Huanjie, et al.
  Udgivet: (2009)
• Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
  af: Allmeroth, Kira, et al.
  Udgivet: (2020)
• Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs
  af: MUJTABA, TASKEEN, et al.
  Udgivet: (2012)